About this trial
This self-crossover, randomized controlled, pilot study aims to collect clinical data of bilateral stimulation of subthalamic nucleus (STN) combined with centromedian (CM) thalamus deep brain stimulation (DBS) for drug resistant epilepsy with motor symptom in adults.
Eligibility criteria
Qualifiers
1) 18-65 Years.
2) Drug Resistant Epilepsy.
Epilepsy diagnosis meeting ILAE criteria
4) >3 Focal or Generalized seizures / month with an inter-seizure interval no great than 30 days.
Disqualifiers
1) Non Motor Epilepsy.
2) Previous diagnosis of psychogenic/non-epileptic seizures.
3) Brain lesion resection or ablation surgery performed less than 6 months.
4) Implanted Vagus nerve stimulation (VNS) or responsive neurostimulation (RNS) devices recommended neither stimulation off the device at least 6 months nor remove the device.
Trial design
Treatments tested in this trial
- Deep brain stimulation